146 related articles for article (PubMed ID: 35318203)
1. Severe hyponatraemia in two patients with breast cancer caused by low-dose cyclophosphamide and precipitated by aprepitant.
Parikh S; Pettit L; AbdelGadir H
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35318203
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide-induced symptomatic hyponatraemia.
Bruining DM; van Roon EN; de Graaf H; Hoogendoorn M
Neth J Med; 2011 Apr; 69(4):192-5. PubMed ID: 21527808
[TBL] [Abstract][Full Text] [Related]
3. Syndrome of inappropriate antidiuretic hormone secretion induced by a single dose of oral cyclophosphamide.
Gilbar PJ; Richmond J; Wood J; Sullivan A
Ann Pharmacother; 2012 Sep; 46(9):e23. PubMed ID: 22911342
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic hyponatremia induced by low-dose cyclophosphamide in patient with systemic lupus erythematosus: A case report.
Chen J; Jin Y; Li C; Li Z
Medicine (Baltimore); 2020 Nov; 99(48):e22498. PubMed ID: 33235058
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hyponatraemia in patients with tick-borne encephalitis--a preliminary study.
Czupryna P; Moniuszko A; Garkowski A; Pancewicz S; Guziejko K; Zajkowska J
Ticks Tick Borne Dis; 2014 Apr; 5(3):284-6. PubMed ID: 24524837
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic hyponatraemia caused by cylophosphamide.
Berger AK; Bellos F; Siegmund A; Eisenbach C; Lordick F
Onkologie; 2009 May; 32(5):280-2. PubMed ID: 19420976
[TBL] [Abstract][Full Text] [Related]
7. [Hyponatraemia associated with the syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH) - options for treatment].
Rudnay M; Hrabčáková P; Lazúrová I
Vnitr Lek; 2012 Jan; 58(1):52-5. PubMed ID: 22448701
[TBL] [Abstract][Full Text] [Related]
8. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
9. [The role of hyponatremia in the rapid onset of coma after Cyclophosphamide].
Delin M; Gilardoni JM; Cremoni M; Ben Hayoun M; Keirle G; Pradelli J; Benzaquen J; Leroy S
Rev Mal Respir; 2022 Jun; 39(6):571-574. PubMed ID: 35659457
[TBL] [Abstract][Full Text] [Related]
10. Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia.
Amoako AO; Brown C; Riley T
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25911354
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on the management of hyponatraemia secondary to SIADH across Europe.
Hoorn EJ; Bouloux PM; Burst V
Best Pract Res Clin Endocrinol Metab; 2012 Mar; 26 Suppl 1():S27-32. PubMed ID: 22469248
[TBL] [Abstract][Full Text] [Related]
12. Hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion in adults with respiratory syncytial virus infection.
Smale M; Freckelton J; Waters M; Grill V
Intern Med J; 2021 Aug; 51(8):1340-1343. PubMed ID: 34423538
[TBL] [Abstract][Full Text] [Related]
13. Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.
Spigset O; Hedenmalm K
Drug Saf; 1995 Mar; 12(3):209-25. PubMed ID: 7619332
[TBL] [Abstract][Full Text] [Related]
14. Severe Hyponatremia During First Cycle of Cyclophosphamide/Doxorubicin Chemotherapy.
Jamhour C; Haddad A; Daw H
Am J Ther; 2023 Jul-Aug 01; 30(4):e369-e371. PubMed ID: 35584371
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of aprepitant in patients with breast cancer].
Tagashira H; Matsuhisa T; Oze I; Kiyoto S; Takahashi M; Hara F; Takabatake D; Takashima S; Aogi K; Osumi S; Eguchi H
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1307-11. PubMed ID: 21829069
[TBL] [Abstract][Full Text] [Related]
16. Severe hyponatremia and diabetes insipidus caused by low-dose cyclophosphamide in breast cancer patients: A case report and literature review.
Chen Y; Li L; Ou R; Wu Y; Pan B; Luo L
Medicine (Baltimore); 2024 Mar; 103(13):e37572. PubMed ID: 38552085
[TBL] [Abstract][Full Text] [Related]
17. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
Estilo A; McCormick L; Rahman M
Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
[TBL] [Abstract][Full Text] [Related]
18. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case/non-case analysis of vigibase.
Beers E; van Puijenbroek EP; Bartelink IH; van der Linden CM; Jansen PA
Drug Saf; 2010 Jan; 33(1):47-55. PubMed ID: 20000866
[TBL] [Abstract][Full Text] [Related]
19. [Hyponatremia secondary to inappropriate antidiuretic hormone secretion].
Zamboli P; De Nicola L; Minutolo R; Iodice C; Avino D; Mascia S; D'Angiò P; Calabria M; Conte G
G Ital Nefrol; 2008; 25(5):554-61. PubMed ID: 18985840
[TBL] [Abstract][Full Text] [Related]
20. Osmotic demyelination syndrome following slow correction of hyponatraemia.
Saunders I; Williams DM; Ruslan AM; Min T
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34373247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
